Amir Weiss

CIK: 0001897057

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (31.3%)

Position reduction

Option Exercises (M)9 (56.3%)

Derivative conversions

Awards (A)2 (12.5%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

TEVA

TEVA PHARMACEUTICAL INDUSTRIES LTD

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Aug 21, 2026
Sale(S)
Direct
2.5K shares at avg. $37.63$94K
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Aug 21, 2026
Exercise(M)
Direct
2.5K shares at avg. $19.61$49K
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Aug 21, 2026
Sale(S)
Direct
6.9K shares at avg. $37.61$261K
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
May 6, 2026
Sale(S)
Direct
10.7K shares at avg. $36.00$384K
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 5, 2026
Exercise(M)
Direct
3.5K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 4, 2026
Award(A)
Restricted Share Units
Direct
11.3K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 4, 2026
Exercise(M)
Direct
10.7K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 4, 2026
Exercise(M)
Direct
5.7K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 3, 2026
Exercise(M)
Direct
5.2K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Dec 16, 2025
Sale(S)
Direct
12.3K shares at avg. $30.20$372K
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Nov 6, 2025
Sale(S)
Direct
12.3K shares at avg. $24.44$301K
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 5, 2025
Award(A)
Restricted Share Units
Direct
14.2K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 5, 2025
Exercise(M)
Direct
3.6K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 4, 2025
Exercise(M)
Direct
10.7K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 4, 2025
Exercise(M)
Direct
5.7K shares-
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Mar 3, 2025
Exercise(M)
Direct
5.2K shares-

		Type	Shares	Price		Ownership
Aug 21, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Sale(S)	2,500	$37.63	$94,077	Direct
Aug 21, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	2,500	$19.61	$49,025	Direct
Aug 21, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Sale(S)	6,945	$37.61	$261,224	Direct
May 6, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Sale(S)	10,679	$36.00	$384,444	Direct
Mar 5, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	3,537	-	$0	Direct
Mar 4, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Award(A) Restricted Share Units	11,280	-	-	Direct
Mar 4, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	10,679	-	$0	Direct
Mar 4, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	5,650	-	$0	Direct
Mar 3, 2026	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	5,179	-	$0	Direct
Dec 16, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Sale(S)	12,300	$30.20	$371,504	Direct
Nov 6, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Sale(S)	12,300	$24.44	$300,564	Direct
Mar 5, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Award(A) Restricted Share Units	14,150	-	-	Direct
Mar 5, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	3,566	-	-	Direct
Mar 4, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	10,676	-	-	Direct
Mar 4, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	5,650	-	-	Direct
Mar 3, 2025	TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD	Exercise(M)	5,179	-	-	Direct

1-16 of 16 transactions

About Weiss Amir

Weiss Amir (SEC CIK 0001897057) files insider reports with the SEC as Chief Accounting Officer of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).

Signal8 holds 10 ownership filings by Weiss Amir, all Form 4s, filed between Mar 5, 2025 and Aug 25, 2026. Those filings report 16 transactions, from Mar 3, 2025 to Aug 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Weiss Amir's filings is in TEL AVIV.

Recent filings by Weiss Amir

Aug 21, 2026: Open-market sale of TEVA shares (Form 4, code S).
Aug 21, 2026: Option exercise of TEVA shares (Form 4, code M).
Aug 21, 2026: Open-market sale of TEVA shares (Form 4, code S).
May 6, 2026: Open-market sale of TEVA shares (Form 4, code S).
Mar 5, 2026: Option exercise of TEVA shares (Form 4, code M).

Other insiders filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Bergwerk Dov, Interim Cheif Legal Officer
Savage Brian, Interim Chief Legal Officer
MIGNONE ROBERTO, Director
Satchi-Fainaro Ronit, Director
Lippman Evan, EVP, Business Development
Zaks Tal Zvi, Director

How to read Form 4 transaction codes